CAMBRIDGE, Mass., June 3, 2014 /PRNewswire/ -- LabCentral, a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups, is announcing important new milestones as it continues to make its mark as the place to be for science innovation. LabCentral has launched a new website and secured significant new sponsor agreements. In addition, a new partnership agreement with Mispro Biotech Services provides LabCentral resident companies full access to Mispro's world-class vivarium facility, steps away from LabCentral, where they can conduct their preclinical and in vivo studies.
Agilent Technologies Inc., BioTek Instruments, Inc., and LI-COR Biosciences are providing state-of-the-art equipment, thereby expanding the full range of studies that residents can conduct at LabCentral's shared laboratory facilities. Agilent has donated a 1290 Infinity HPLC system for liquid chromatography studies and a 2100 Bioanalyzer for electrophoresis and flow cytometry. BioTek has provided an ELx405™ Select Microplate Washer, and LI-COR has donated an infrared imaging instrument, the Odyssey® CLx System, and an Odyssey Fc Dual-Mode Imaging System for infrared and chemiluminescent use, which are critical for quantitative Western Blots and other near-infrared fluorescent-detection applications.
LabCloud Inc. has provided its all-in-one scientific informatics and e-procurement platform to assist resident companies in managing data and information as well as facilitating, managing, and tracking purchases made by them through LabCentral's shared-purchasing program. Alexandria Real Estate Equities became a sponsor to expand LabCentral's access to functional laboratory space in Kendall Square. Steady Vision created the new LabCentral website, designed to capture the creative and vibrant spirit of the Kendall Square bioinnovation hub.
"Providing biotech entrepreneurs a fertile environment with the best infrastructure, equipment, and services to enable their unfettered practice of science – that's LabCentral's raison d'etre – and our sponsors and partners make that possible," said Dr. Fruehauf. "There's a famous African proverb, 'it takes a village to raise a child.' We think the same is true in creating successful biotech startups. With the help of our sponsors, we are able to build an environment that fosters a can-do atmosphere of thought-sharing and creative exchange. We explored many potential models in establishing LabCentral and chose to organize as a nonprofit. This has proven an ideal platform to engage the many different stakeholders required to transform good ideas into home-run products that improve health – scientists, entrepreneurs, government, academia, and industry."
Only seven months since its doors opened to residents, LabCentral regularly hosts delegations of scientists, funders, and policymakers from around the nation and the world, eager to learn more about LabCentral's novel model. Twenty startups are expected to be in residence by August and the shared laboratory space should be at capacity by year's end. LabCentral has leveraged its original $5 million grant from the Massachusetts Life Sciences Center (MLSC) to raise an additional $15 million in donations of cash, state-of-the-art equipment, and in-kind services, as well as an additional $5 million grant from MLSC to build-out of additional space of equal size near LabCentral's existing 700 Main Street location. The business community is taking notice.
In recognition of this success, co-founder and president, Dr. Johannes Fruehauf, has been named a finalist in the Ernst & Young Entrepreneur Of The Year 2014 New England awards program. The awards program, one of the most prestigious business awards for entrepreneurs, recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities.
Commenting on the nomination, Dr. Fruehauf said, "It is truly an honor to be in such esteemed company as a finalist. LabCentral is a shared space and our success to date is due to a shared effort. This recognition is owed to the creativity, tenacity, and hard work of our team that includes my co-founders Peter Parker and Tim Rowe, LabCentral's extraordinarily dedicated staff, and our terrific partners."
About LabCentral (www.labcentral.org; twitter @labcentral)
A 28,000 square-foot facility in the heart of the Kendall Square, Cambridge, biotech innovation hub, LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups. It offers fully permitted laboratory and office space for as many as 25 startups comprising approximately 100 scientists and entrepreneurs. LabCentral provides first-class facility and administrative support, skilled laboratory personnel, a domain-relevant expert speaker series ‒ as well as the other critical services and support that early-stage companies need to begin laboratory operations on day one. A private, nonprofit institution, LabCentral was funded in part by a $5 million grant from the Massachusetts Life Sciences Center, with support from its real-estate partner, MIT. Founding sponsors include Triumvirate Environmental and Johnson & Johnson Innovation.
Caroline A. Grossman | +1.781.771.5579 |email@example.com